Literature DB >> 28946186

Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway.

Ying Wang1, Hui-Lan Lu1, Yong-Dong Liu2, Li-Yun Yang3, Qing-Kun Jiang1, Xiao-Jun Zhu4, Hua-Nan Fan5, Yong Qian6.   

Abstract

Cryptotanshinone, a natural compound isolated from the roots of Salvia miltiorrhiza Bge (Danshen), has been found to induce cancer cells apoptosis and impair cell migration and invasion in various malignancies, but its antiproliferation and chemosensitization effects of Cryptotanshinone on tongue squamous cell carcinoma(TSCC)still remain fully elucidated. In this study, the effects of Cryptotanshinone on the proliferation, apoptosis and cell cycle of human TSCC cells, including CAL 27 and SCC 9 cells, were measured. The results demonstrated that Cryptotanshinone dose-dependently inhibited cell migration and proliferation, and induced apoptosis in TSCC cells. Mechanistic study revealed that Cryptotanshinone suppressed the expression of p-STAT3, Bcl-2, CDK2, Snail and MMP2, and induced the expression of E-cadherin, P53, P21 and β-catenin. Furthermore, we found that the combination treatment of Cryptotanshinone and paclitaxel more effectively inhibited TSCC cell proliferation and migration, and induced apoptosis via the inhibition of STAT3 signaling pathway. In brief, we provided the new evidence that Cryptotanshinone could enhance the efficacy of paclitaxel on TSCC cells in vitro and demonstrated that STAT3 signaling pathway played an important role in Cryptotanshinone-induced anticancer effects in human TSCC.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cryptotanshinone; Paclitaxel; STAT3; Tongue squamous cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28946186     DOI: 10.1016/j.biopha.2017.09.062

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Association of SP1 rs1353058818 and STAT3 rs1053004 gene polymorphisms with human tongue squamous cell carcinoma.

Authors:  Heqing Lai; Guochao Xu; Haifeng Meng; Haiying Zhu
Journal:  Biosci Rep       Date:  2019-07-23       Impact factor: 3.840

Review 2.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

3.  Cryptotanshinone chemosensitivity potentiation by TW-37 in human oral cancer cell lines by targeting STAT3-Mcl-1 signaling.

Authors:  In-Hyoung Yang; Seung-Hyun Hong; Minjung Jung; Chi-Hyun Ahn; Hye-Jung Yoon; Seong Doo Hong; Sung-Dae Cho; Ji-Ae Shin
Journal:  Cancer Cell Int       Date:  2020-08-26       Impact factor: 5.722

4.  Perspectives on the Clinical Development of NRF2-Targeting Drugs.

Authors:  Diego Lastra; Raquel Fernández-Ginés; Gina Manda; Antonio Cuadrado
Journal:  Handb Exp Pharmacol       Date:  2021

5.  Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm.

Authors:  Linling Jin; Zhenzhen Wu; Yanli Wang; Xin Zhao
Journal:  Chin Med       Date:  2020-06-30       Impact factor: 5.455

6.  Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.

Authors:  Yufei Yang; Yue Cao; Lihua Chen; Fei Liu; Zihao Qi; Xi Cheng; Ziliang Wang
Journal:  Cancer Med       Date:  2018-08-09       Impact factor: 4.452

7.  Salviolone from Salvia miltiorrhiza Roots Impairs Cell Cycle Progression, Colony Formation, and Metalloproteinase-2 Activity in A375 Melanoma Cells: Involvement of P21(Cip1/Waf1) Expression and STAT3 Phosphorylation.

Authors:  Valentina Zanrè; Rachele Campagnari; Antonietta Cerulli; Milena Masullo; Alessia Cardile; Sonia Piacente; Marta Menegazzi
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

8.  β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo.

Authors:  Haiye Wang; Yingyi Ma
Journal:  Cancer Cell Int       Date:  2022-07-31       Impact factor: 6.429

Review 9.  The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients.

Authors:  Li Fu; Bing Han; Yang Zhou; Jie Ren; Wenzhi Cao; Gopal Patel; Guoyin Kai; Jun Zhang
Journal:  Front Pharmacol       Date:  2020-03-19       Impact factor: 5.810

10.  Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway.

Authors:  Yadong Liu; Fanlu Lin; Yaodong Chen; Rui Wang; Jiannan Liu; Yinshan Jin; Ruihua An
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.